Volume 34 Issue 6
Nov.  2018
Turn off MathJax
Article Contents
Abstract
References
Related Articles
LU Zhen-qiang. Protective Effect of Hydroxysafflor Yellow A Combined with Astragaloside Ⅳ on Chronic Kidney Disease[J]. Journal of Nanjing University of traditional Chinese Medicine, 2018, 34(6): 589-592.
Citation: LU Zhen-qiang. Protective Effect of Hydroxysafflor Yellow A Combined with Astragaloside Ⅳ on Chronic Kidney Disease[J]. Journal of Nanjing University of traditional Chinese Medicine, 2018, 34(6): 589-592.
shu

Protective Effect of Hydroxysafflor Yellow A Combined with Astragaloside Ⅳ on Chronic Kidney Disease

More Information
    Graphical Abstract
    • Abstract
  • OBJECTIVE To observe the preventive and therapeutic effects of hydroxysafflor yellow A combined with astragaloside Ⅳ on chronic kidney disease in rats and to explore its mechanism. METHODS 36 male Sprague-Dawley rats were randomly divided into sham operation group， model group and treatment group (HSYA+As-Ⅳ) by rat 5/6 nephrectomy model. One week after continuous administration， rats were sacrificed one month later. Serum levels of serum creatinine (Scr) and urea nitrogen (BUN) were measured before and after treatment in each group. The levels of SOD and MDA were measured to show oxidative stress changes. HE staining was used to observe the small groups. Histopathological changes in rat kidney， Western blot was used to detect SIRT1， eNOS and PGC-1α protein in kidney tissues of mice. RESULTS Compared with the model group， the treatment group reduced the levels of increased SCr and BUN， improved renal pathological changes， significantly reduced renal oxidative stress， and increased the expression of SIRT1， eNOS and PGC-1α proteins. CONCLUSION HSYA combined with As-Ⅳ may exert anti-chronic kidney disease through SIRT1/eNOS/PGC-1α pathway and oxidative stress.
    • FullText(HTML)
    • References (25)
  • [1]
    KHAN Z， PANDEY M. Role of kidney biomarkers of chronic kidney disease: An update[J]. Saudi J Biol Sci， 2014， 21(4): 294-299.
    [2]
    LEE SY， KIM SI， CHOI ME. Therapeutic targets for treating fibrotic kidney diseases[J]. Transl Res， 2015， 165(4): 512-530.
    [3]
    段昱方， 张海滨. 慢性肾脏病的中医治疗概况[J]. 现代中西医结合杂志， 2012， 21（28）: 3186-3189.
    [4]
    吴国伟， 吴劼扬， 郑卫华， 等. 慢性肾脏病与中医证型的关系探讨[J]. 浙江中医杂志， 2014， 49(8): 565-566.
    [5]
    董华玲， 马华. 中药芪红合剂对肾间质纤维化模型大鼠肾组织中基质金属蛋白酶组织抑制剂-1表达的影响[J]. 中国医药导报， 2008， 5(28): 5-8.
    [6]
    张选明， 杨百京， 叶学锋， 等. 补阳还五汤对肾间质纤维化大鼠模型胶原纤维和TGF-β1的作用[J]. 中药药理与临床， 2011， 27（6）: 3-6.
    [7]
    杨秀炜， 庞敏. 黄芪红花注射液合用对糖尿病肾病血流变的影响[J]. 辽宁中医杂志， 2003， 30(12): 994-994.
    [8]
    范愈燕， 吕翠岩， 朱斌， 等. 黄芪甲苷对链脲佐菌素诱导糖尿病大鼠肾脏保护机制探讨[J]. 中华中医药杂志， 2017， 32（1）: 294-298.
    [9]
    高燕， 谭虎， 常显， 等. 红花黄色素对糖尿病肾病的保护作用[J]. 中国老年学杂志， 2018， 38（6）: 1433-1435.
    [10]
    LITBARG NO， VUJICIC S， SETTY S， et al. A novel model of surgical injury in adult rat kidney: a "pouch model"[J]. Sci Rep， 2013（3）: 2890.
    [11]
    李忠， 张培华. 黄芪甲苷经TGF-β/Smad 信号通路对糖尿病肾病大鼠肾脏的影响[J]. 广东医学， 2016， 37(11): 1623-1628.
    [12]
    李会会， 胡娜平， 刘美佑， 等. 大黄酸和羟基红花黄色素 A 单用及配伍对慢性肾病的保护作用研究[J]. 药物评价研究， 2015， 38(6): 607-611.
    [13]
    张昶， 周鹰.黄芪在慢性肾病中的运用[J]. 新中医， 2009， 41（1）: 88-89.
    [14]
    毕立明， 朱冬云， 马济佩. 中西医对慢性肾脏病进展机制的共同认识及思考[J]. 辽宁中医杂志， 2011， 38(10): 2041-2043.
    [15]
    ZEISBERG M， NEILSON EG. Mechanisms of tubulointerstitial fibrosis[J]. J Am Soc Nephrol， 2010， 21(11): 1819-1834.
    [16]
    曹荣， 张晓燕， 康继宏. SIRT1在肾脏疾病中的作用[J]. 生理科学进展， 2013， 44(4): 305-309.
    [17]
    HE W， WANG Y， ZHANG MZ， et al. SIRT1 activation protects the mouse renal medulla from oxidative injury[J]. J Clin Invest， 2010， 120(4): 1056-1068.
    [18]
    KUME S， UZU T， HORIIKE K， et al. Calorie restriction enhances cell adaptation to hypoxia through SIRT1-dependent mitochondrial autophagy in mouse aged kidney[J]. J Clin Invest， 2010， 120(4): 1043-1055.
    [19]
    李博， 田瑞霞， 杨卫景. 等. PGC-1α的功能与代谢病[J]. 中国生物化学与分子生物学报， 2011， 27(11): 1013-1018.
    [20]
    TERESA CL， JOHN JL， BRIAN NF， et al. PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction， abnormal weight control and hepatic steatosis[J]. PLoS Biol， 2005， 3(4): 672-687.
    [21]
    FURRER R， HANDSCHIN C. Exercise and PGC-1α in inflammation and chronic disease[J]. Nature， 2015， 66(12): 317-320.
    [22]
    VALLE I， ALVAREZ-BARRIENTOS A， ARZA E， et al. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells[J]. Cardiovasc Res， 2005， 66(3): 562-573.
    [23]
    米琼宇， 邰婷， 潘玉琴， 等. 黄芪甲苷Ⅳ通过影响β-actin对内皮型一氧化氮合酶的调节作用[J]. 现代生物医学进展， 2013， 13(29): 5644-5648.
    [24]
    CHEN J， ZHOU Y， MUELLER-STEINER S， et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling[J]. J Biol Chem， 2005， 280(48): 40364-40374.
    [25]
    NISOLI E， TONELLO C， CARDILE A， et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS[J].Science， 2005， 310(5746): 314-317.
    • Related Articles

  • Related Articles

    [1]CHEN Yuan, WANG Meihui, LI Wei, XU Xuefen. Artesunate Enhances the Sensitization of Hepatocellular Carcinoma Cells by Inhibiting Nrf2/HIF-1α in Hypoxia[J]. Journal of Nanjing University of traditional Chinese Medicine, 2025, 41(2): 243-250. DOI: 10.14148/j.issn.1672-0482.2025.0243
    [2]LU Songxia, DUAN Qiangjun, WANG Ruilin, GUO Xi, GAO Min, HUANG Rongrong. Study on the Effect of Baitouweng Decoction on VVC Mice by Regulating PI3K/AKT-HIF-1α Pathway[J]. Journal of Nanjing University of traditional Chinese Medicine, 2024, 40(8): 804-811. DOI: 10.14148/j.issn.1672-0482.2024.0804
    [3]WEI Wei, PENG Chenjian, GU Renjun, YAN Xiwu, YE Jiapeng, HUANG Guicheng, SUN Luning. Effects of Serum Containing Wenjing Tongluo Decoction on Mouse Chondrocyte Injury and IκB-ζ/HIF-1α/LDHA Axis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2024, 40(5): 469-478. DOI: 10.14148/j.issn.1672-0482.2024.0469
    [4]LI Juan, ZHANG Zhong-le, WU Jia-zhen, SHEN Hong-yi. Effects of Baicalin on High Fat-Induced Lipid Accumulation and SIRT1 Related Factors Expression of HepG2 Cells in vitro[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(2): 258-262. DOI: 10.14148/j.issn.1672-0482.2021.0258
    [5]SUIMiao, CHENGuo-fang, MAOXiao-dong, WEIXiao, WUBo, HUANGHui, FANYao-fu, LIUChao. The Mechanism Exploration of Gegen Qinlian Decoction on Hepatic Insulin Resistance Through SIRT1/FoxO1 Pathway[J]. Journal of Nanjing University of traditional Chinese Medicine, 2018, 34(6): 578-582.
    [6]XIAO Yun, PENG Yong-jun. Effect of Electroacupuncture on Levels of Serum HIF-1α and VEGF in the Treatment of Patients with Acute Cerebral Infarction[J]. Journal of Nanjing University of traditional Chinese Medicine, 2018, 34(2): 128-131.
    [7]DING Ya-juan, LU Sheng-feng, CHEN Xia, PENG Yong-jun, ZHU Bing-mei. Effect of Electroacupuncture Pretreatment at Different Time on Myocardial Ischemia Injury and Expression of HIF-1α[J]. Journal of Nanjing University of traditional Chinese Medicine, 2017, 33(1): 40-43.
    [8]Emodin Regulates Glucose Uptake by Activating Sirt1 in 3T3-L1 Adipocytes[J]. Journal of Nanjing University of traditional Chinese Medicine, 2014, 30(6): 546-549.
    [9]TANGQun, HEZe-yun, CHENLi, XUWen-feng, ZENGHai-fei. Effects of Liuwei Dihuang Decoction on Expression of HIF-1α and CTGF in Kidney Tissues of Chronic Renal Failure Rats[J]. Journal of Nanjing University of traditional Chinese Medicine, 2013, 29(4): 342-346.
    [10]Cao YueXin;Xu Biao;Wang JianAn;Yang ShenQi;Liu YunHai. Effect of Puerarin on Activity of AGEs, HUVECs and eNOS and on MDA Content[J]. Journal of Nanjing University of traditional Chinese Medicine, 2005, 21(5): 302-304.

  • Cited by

    Periodical cited type(7)

    1. 美丽. 蒙药古日古木-13的药理作用及临床应用研究进展. 中国民族医药杂志. 2025(02): 68-70 .
    2. 谢飞，周美兰. 羟基红花黄色素A抑制高糖诱导的小鼠肾足细胞损伤. 基础医学与临床. 2021(01): 27-32 .
    3. 徐维佳，陈揭剑，严丽群，张勇，王丽萍，庄永泽. 黄芪甲苷对马兜铃酸诱导的巨噬细胞M1型极化的作用及机制研究. 现代生物医学进展. 2021(06): 1040-1045 .
    4. 尤心怡，王文凤，徐霞，张文彤，房文洁，谭志伟，姜丽. 补阳还五汤治疗动脉粥样硬化的物质基础及作用机制研究进展. 中药新药与临床药理. 2021(10): 1575-1581 .
    5. 李敏琤. 肾康注射液治疗慢性肾脏病疗效观察. 湖北中医杂志. 2021(11): 37-39 .
    6. 白雪，陆璐，刘振权，边艳琴. 黄芪甲苷抗二甲基亚硝胺诱导肝纤维化大鼠效应研究. 湖南中医药大学学报. 2020(01): 22-27 .
    7. 孟祥善，周玉梅，代晓华，刘萍. 黄芪ISSR标记遗传多样性及其与主要药用成分的关联分析. 中国药学杂志. 2019(24): 2060-2070 .

    Other cited types(10)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (701) PDF downloads (700) Cited by(17)
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return